Lanean...
Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report
INTRODUCTION: Natalizumab is a new treatment for relapsing-remitting multiple sclerosis. Because of limited experience of this treatment, medical professionals must be alert to possible side effects. CASE PRESENTATION: We present a 34-year-old Caucasian woman with relapsing-remitting multiple sclero...
Gorde:
| Egile Nagusiak: | , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2009
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2827173/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4076/1752-1947-3-8955 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|